Cadence Bank United Therapeutics Corp Transaction History

Cadence Bank

$1.45 Billion
Q3 2024

A detailed history of Cadence Bank transactions in United Therapeutics Corp stock. As of the latest transaction made, Cadence Bank holds 3,945 shares of UTHR stock, worth $1.42 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

3,945

Previous 4,006 1.52%

Holding current value

$1.42 Million

Previous $1.28 Million 10.74%

% of portfolio

0.1%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$311.04 - $363.55 $18,973 - $22,176	-61 Reduced 1.52%	3,945 $1.41 Million
Q1 2024 May 14, 2024	BUY	$210.76 - $249.51 $5,479 - $6,487	26 Added 0.65%	4,006 $920,000
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $10,054 - $11,416	-49 Reduced 1.22%	3,980 $878,000
Q1 2023 May 12, 2023	SELL	$212.99 - $276.17 $12,779 - $16,570	-60 Reduced 1.47%	4,029 $902,000
Q4 2022 Feb 13, 2023	SELL	$205.95 - $280.43 $5,148 - $7,010	-25 Reduced 0.61%	4,089 $1.14 Million
Q2 2022 Aug 12, 2022	SELL	$174.81 - $241.14 $23,424 - $32,312	-134 Reduced 3.15%	4,114 $969,000
Q1 2022 May 13, 2022	SELL	$166.16 - $213.96 $29,244 - $37,656	-176 Reduced 3.98%	4,248 $762,000
Q4 2021 Feb 11, 2022	BUY	$184.32 - $216.08 $2,027 - $2,376	11 Added 0.25%	4,424 $956,000
Q3 2021 Nov 10, 2021	BUY	$179.86 - $214.88 $21,223 - $25,355	118 Added 2.75%	4,413 $815,000
Q2 2021 Aug 13, 2021	BUY	$170.47 - $211.93 $17,217 - $21,404	101 Added 2.41%	4,295 $770,000
Q1 2021 May 11, 2021	BUY	$153.94 - $174.85 $15,701 - $17,834	102 Added 2.49%	4,194 $702,000
Q4 2020 Feb 04, 2021	BUY	$101.87 - $151.79 $2,852 - $4,250	28 Added 0.69%	4,092 $621,000
Q2 2020 Jul 27, 2020	BUY	$92.74 - $125.82 $649 - $880	7 Added 0.17%	4,064 $492,000
Q1 2020 Apr 30, 2020	BUY	$79.39 - $115.35 $11,273 - $16,379	142 Added 3.63%	4,057 $385,000
Q4 2019 Feb 04, 2020	BUY	$78.31 - $95.34 $8,770 - $10,678	112 Added 2.95%	3,915 $345,000
Q3 2019 Nov 06, 2019	SELL	$74.85 - $85.99 $1,571 - $1,805	-21 Reduced 0.55%	3,803 $303,000
Q2 2019 Jul 30, 2019	BUY	$76.06 - $120.81 $7,377 - $11,718	97 Added 2.6%	3,824 $299,000
Q1 2019 May 02, 2019	SELL	$107.15 - $126.84 $4,928 - $5,834	-46 Reduced 1.22%	3,727 $437,000
Q4 2018 Feb 07, 2019	SELL	$101.4 - $128.73 $31,129 - $39,520	-307 Reduced 7.52%	3,773 $410,000
Q3 2018 Oct 25, 2018	BUY	$113.81 - $129.46 $22,306 - $25,374	196 Added 5.05%	4,080 $522,000
Q2 2018 Aug 09, 2018	BUY	$101.14 - $118.31 $40,152 - $46,969	397 Added 11.39%	3,884 $440,000
Q1 2018 May 03, 2018	BUY	$107.21 - $151.94 $27,552 - $39,048	257 Added 7.96%	3,487 $392,000
Q4 2017 Feb 12, 2018	BUY	$118.58 - $151.28 $383,013 - $488,634	3,230	3,230 $0

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.3M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank with notifications on news.

Account